Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 111

1.

Renal survival in proteinase 3 and myeloperoxidase ANCA-associated systemic vasculitis.

de Joode AA, Sanders JS, Stegeman CA.

Clin J Am Soc Nephrol. 2013 Oct;8(10):1709-17. doi: 10.2215/CJN.01020113. Epub 2013 Jul 11.

PMID:
23846462
[PubMed - indexed for MEDLINE]
2.

Renal survival and prognostic factors in patients with PR3-ANCA associated vasculitis with renal involvement.

Slot MC, Tervaert JW, Franssen CF, Stegeman CA.

Kidney Int. 2003 Feb;63(2):670-7.

PMID:
12631133
[PubMed - indexed for MEDLINE]
3.

The outcomes of patients with ESRD and ANCA-associated vasculitis in Australia and New Zealand.

Tang W, Bose B, McDonald SP, Hawley CM, Badve SV, Boudville N, Brown FG, Clayton PA, Campbell SB, Peh CA, Johnson DW.

Clin J Am Soc Nephrol. 2013 May;8(5):773-80. doi: 10.2215/CJN.08770812. Epub 2013 Jan 24.

PMID:
23349331
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Clinical outcomes of Japanese MPO-ANCA-related nephritis: significance of initial renal death for survival.

Watanabe K, Tani Y, Kimura H, Tanaka K, Hayashi Y, Asahi K, Sato K, Sato M, Matsushima M, Nakayama M, Watanabe T.

Intern Med. 2012;51(15):1969-76. Epub 2012 Aug 1.

PMID:
22864120
[PubMed - indexed for MEDLINE]
Free Article
5.

Classification of antineutrophil cytoplasmic autoantibody vasculitides: the role of antineutrophil cytoplasmic autoantibody specificity for myeloperoxidase or proteinase 3 in disease recognition and prognosis.

Lionaki S, Blyth ER, Hogan SL, Hu Y, Senior BA, Jennette CE, Nachman PH, Jennette JC, Falk RJ.

Arthritis Rheum. 2012 Oct;64(10):3452-62. doi: 10.1002/art.34562.

PMID:
23023777
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

ANCA-associated vasculitis with renal involvement: an outcome analysis.

Weidner S, Geuss S, Hafezi-Rachti S, Wonka A, Rupprecht HD.

Nephrol Dial Transplant. 2004 Jun;19(6):1403-11. Epub 2004 Apr 6.

PMID:
15069175
[PubMed - indexed for MEDLINE]
Free Article
7.

Early plasma exchange improves outcome in PR3-ANCA-positive renal vasculitis.

Gregersen JW, Kristensen T, Krag SR, Birn H, Ivarsen P.

Clin Exp Rheumatol. 2012 Jan-Feb;30(1 Suppl 70):S39-47. Epub 2012 May 10.

PMID:
22510451
[PubMed - indexed for MEDLINE]
8.

Prolonged infections associated with antineutrophil cytoplasmic antibodies specific to proteinase 3 and myeloperoxidase: diagnostic and therapeutic challenge.

Bonaci-Nikolic B, Andrejevic S, Pavlovic M, Dimcic Z, Ivanovic B, Nikolic M.

Clin Rheumatol. 2010 Aug;29(8):893-904. doi: 10.1007/s10067-010-1424-4. Epub 2010 Mar 20.

PMID:
20306213
[PubMed - indexed for MEDLINE]
9.

Long-term outcome of severe alveolar haemorrhage in ANCA-associated vasculitis: a retrospective cohort study.

Hruskova Z, Casian AL, Konopasek P, Svobodova B, Frausova D, Lanska V, Tesar V, Jayne DR.

Scand J Rheumatol. 2013;42(3):211-4. doi: 10.3109/03009742.2012.754939. Epub 2013 Feb 4.

PMID:
23374071
[PubMed - indexed for MEDLINE]
10.

Clinical analysis of ANCA-associated renal vasculitis patients with chronic dialysis.

Chen YX, Zhang W, Chen XN, Ni LY, Shen PY, Wang WM, Chen N.

Clin Exp Rheumatol. 2014 May-Jun;32(3 Suppl 82):S5-10. Epub 2014 Jan 30.

PMID:
24480250
[PubMed - indexed for MEDLINE]
11.

Factors influencing patient survival and renal function outcome in pulmonary-renal syndrome associated with ANCA (+) vasculitis: a single-center experience.

Stangou M, Asimaki A, Bamichas G, Christidou F, Zoumbaridis N, Natse T, Galanis N, Christaki P, Patakas D, Sombolos K.

J Nephrol. 2005 Jan-Feb;18(1):35-44.

PMID:
15772921
[PubMed - indexed for MEDLINE]
12.

Histologic and immunohistologic study and clinical presentation of ANCA-associated glomerulonephritis with correlation to ANCA antigen specificity.

Vizjak A, Rott T, Koselj-Kajtna M, Rozman B, Kaplan-Pavlovcic S, Ferluga D.

Am J Kidney Dis. 2003 Mar;41(3):539-49.

PMID:
12612976
[PubMed - indexed for MEDLINE]
13.

Revisiting ANCA-associated vasculitis in systemic sclerosis: clinical, serological and immunogenetic factors.

Derrett-Smith EC, Nihtyanova SI, Harvey J, Salama AD, Denton CP.

Rheumatology (Oxford). 2013 Oct;52(10):1824-31. doi: 10.1093/rheumatology/ket213. Epub 2013 Jul 5.

PMID:
23832959
[PubMed - indexed for MEDLINE]
14.

Long-term follow-up of patients with severe ANCA-associated vasculitis comparing plasma exchange to intravenous methylprednisolone treatment is unclear.

Walsh M, Casian A, Flossmann O, Westman K, Höglund P, Pusey C, Jayne DR; European Vasculitis Study Group (EUVAS).

Kidney Int. 2013 Aug;84(2):397-402. doi: 10.1038/ki.2013.131. Epub 2013 Apr 24.

PMID:
23615499
[PubMed - indexed for MEDLINE]
15.

Classification of clinical subtypes, patient survival, kidney prognosis, and relapse in patients with MPO-ANCA-associated vasculitis: a single-center experience.

Nakabayashi K, Arimura Y, Yoshihara K, Fukuoka T, Karube M, Yamato T, Koji H, Ikegaya N, Ohtuka T, Kawashima S, Sudo M, Yamada A.

Mod Rheumatol. 2009;19(4):420-6. doi: 10.1007/s10165-009-0182-0. Epub 2009 Jun 12.

PMID:
19521745
[PubMed - indexed for MEDLINE]
16.

Increased circulating levels of proteinase 3 in patients with anti-neutrophilic cytoplasmic autoantibodies-associated systemic vasculitis in remission.

Ohlsson S, Wieslander J, Segelmark M.

Clin Exp Immunol. 2003 Mar;131(3):528-35.

PMID:
12605707
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

A retrospective study on outcome of microscopic polyangiitis in chronic renal replacement therapy.

Merino JL, Galeano C, Espejo B, Rivera M, Fernández-Lucas M, Caldés S, Plana MN, Letosa M, Teruel JL, Quereda C, Ortuño J.

Nephrol Dial Transplant. 2011 Apr;26(4):1360-6. doi: 10.1093/ndt/gfq523. Epub 2010 Sep 1.

PMID:
20810451
[PubMed - indexed for MEDLINE]
Free Article
18.

Predictors of relapse and treatment resistance in antineutrophil cytoplasmic antibody-associated small-vessel vasculitis.

Hogan SL, Falk RJ, Chin H, Cai J, Jennette CE, Jennette JC, Nachman PH.

Ann Intern Med. 2005 Nov 1;143(9):621-31.

PMID:
16263884
[PubMed - indexed for MEDLINE]
19.

Clinicoepidemiological manifestations of RPGN and ANCA-associated vasculitides: an 11-year retrospective hospital-based study in Japan.

Suzuki Y, Takeda Y, Sato D, Kanaguchi Y, Tanaka Y, Kobayashi S, Suzuki K, Hashimoto H, Ozaki S, Horikoshi S, Tomino Y.

Mod Rheumatol. 2010 Feb;20(1):54-62. doi: 10.1007/s10165-009-0239-0. Epub 2009 Oct 10.

PMID:
19821007
[PubMed - indexed for MEDLINE]
20.

Prediction of relapses in PR3-ANCA-associated vasculitis by assessing responses of ANCA titres to treatment.

Sanders JS, Huitma MG, Kallenberg CG, Stegeman CA.

Rheumatology (Oxford). 2006 Jun;45(6):724-9. Epub 2006 Jan 6.

PMID:
16399845
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk